According to certain clinical trials, the type-2 diabetes drug Actos may carry an increased risk of congestive heart failure in addition to the more widely known Actos bladder cancer side effects.

When Actos was first introduced in the American drug market in 1999, the drug and its maker Takeda Pharmaceuticals were praised for Actos effectiveness in lowering blood sugar and helping patients manage type-2 diabetes symptoms. However, according to various medical reports and Actos lawsuits, several patients have suffered congestive heart failure after using the diabetes drug.

In fact, the risk of Actos heart failure is so high that the FDA now requires Takeda to include a black box warning on Actos label and packaging. This Actos black box warning emphasizes the significant chance of developing Actos congenital heart failure for patients with and without a history of heart problems and complications.

According to one Actos clinical trial, over 5,000 patients were treated with Actos or a placebo, and according to the findings a large percentage of patients experienced serious heart failure while on Actos.

Additionally, the incidence of death as a result of heart failure is higher than normal for patients using Actos. Despite these early clinical trial findings linking Actos to congenital heart failure and bladder cancer, the drug was still released in the United States.

Another Actos side effect that occurs in conjunction with Actos heart failure is edema, that is the accumulation of fluids in the body. When someone develops heart failure, the body also becomes congested with fluid, resulting in major organs shutting down.

Fluid may then continue to build up in tissues, livers, lungs, and even in the extremities. Because of the already existing Actos side effect of edema, the fluid buildup may exacerbate heart problems like congenital heart failure.

Actos Bladder Cancer Side Effects

Actos is a type-2 diabetes drug treatment designed and sold by Takeda and marketed by Eli Lilly. Since the drug’s inception, Takeda has aggressively promoted Actos  throughout the United States and other countries  with the help of Eli Lilly.

Over the last 20 years, Takeda and Eli Lilly have made billions of dollars in annual revenue from the thousands of Actos users who use this drug to manage diabetes symptoms. However, Takeda and Lilly are now facing thousands of Actos lawsuits filed by consumers who allege they developed bladder cancer or other serious Actos side effects after taking the drug.

In addition to the increased risk of bladder cancer and congestive heart failure, many Actos consumers have reported other side effects related to using the type-2 diabetes treatment. These Actos side effects can include:

• Chronic kidney disease
• Liver failure
• Lactic acidosis
• Bone fracture
• Rapid and excessive weight gain
• Difficulty breathing
• Edema (or fluid retention)

Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual Actos lawsuit or Actos class action lawsuit is best for you. [In general, Actos bladder cancer lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.

Learn More